BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative)

A myelodysplastic/myeloproliferative disorder characterized by myelodysplasia associated with bone marrow and peripheral blood patterns similar to CHRONIC MYELOID LEUKEMIA, but cytogenetically lacking a PHILADELPHIA CHROMOSOME or bcr/abl fusion gene (GENES, ABL).
Also Known As:
Leukemia, Myeloid, Philadelphia Negative; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Leukemia, Myelogenous, Ph1 Negative; Leukemia, Myelogenous, Ph1-Negative; Leukemia, Myeloid, Chronic, Atypical; Leukemia, Myeloid, Ph1 Negative; Leukemia, Myeloid, Ph1-Negative; Myelogenous Leukemia, Ph1-Negative; Myeloid Leukemia, Ph1-Negative; Leukemia, Ph1-Negative Myelogenous; Leukemia, Ph1-Negative Myeloid; Leukemia, Philadelphia-Negative Myeloid; Leukemias, Ph1-Negative Myelogenous; Leukemias, Ph1-Negative Myeloid; Leukemias, Philadelphia-Negative Myeloid; Myelogenous Leukemia, Ph1 Negative; Myelogenous Leukemias, Ph1-Negative; Myeloid Leukemia, Ph1 Negative; Myeloid Leukemia, Philadelphia Negative; Myeloid Leukemias, Ph1-Negative; Myeloid Leukemias, Philadelphia-Negative; Ph1-Negative Myelogenous Leukemia; Ph1-Negative Myelogenous Leukemias; Ph1-Negative Myeloid Leukemia; Ph1-Negative Myeloid Leukemias; Philadelphia-Negative Myeloid Leukemia; Philadelphia-Negative Myeloid Leukemias; Atypical Chronic Myeloid Leukemia; Chronic Myeloid Leukemia, Atypical; Leukemia, Myeloid, Philadelphia-Negative; Myeloid Leukemia, Philadelphia-Negative
Networked: 31 relevant articles (0 outcomes, 2 trials/studies)

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Primary Myelofibrosis (Myelosclerosis)
3. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
4. Hematologic Neoplasms (Hematological Malignancy)
5. Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)


1. Cross, Nicholas C P: 5 articles (09/2010 - 10/2004)
2. Chase, Andrew: 3 articles (09/2010 - 04/2005)
3. Reiter, Andreas: 3 articles (09/2010 - 04/2005)
4. Grand, Francis H: 3 articles (06/2009 - 10/2004)
5. Kavelaars, François G: 2 articles (06/2015 - 05/2015)
6. Valk, Peter J M: 2 articles (06/2015 - 05/2015)
7. Ammatuna, Emanuele: 2 articles (06/2015 - 05/2015)
8. Touw, Ivo P: 2 articles (06/2015 - 05/2015)
9. van Lom, Kirsten: 2 articles (06/2015 - 05/2015)
10. Eefting, Matthias: 2 articles (06/2015 - 05/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to BCR-ABL Negative Atypical Chronic Myeloid Leukemia:
1. Carrier Proteins (Binding Protein)IBA
2. imatinib (Gleevec)FDA Link
3. Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
4. Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
5. Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
6. Pyridinolcarbamate (P23)IBA
7. Phosphotransferases (Kinase)IBA
8. INCB018424IBA
9. Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10. Tyrosine (L-Tyrosine)FDA Link

Therapies and Procedures

1. Transplantation (Transplant Recipients)
2. Hematopoietic Stem Cell Transplantation
3. Immunotherapy
4. Drug Therapy (Chemotherapy)